United Kingdom · Question · Written question
UIN 70315
Coronavirus: Drugs
Introduced
5 November 2021
Last action
15 November 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 November 2021
Summary
To ask the Secretary of State for Health and Social Care, if he will set out his timeframe for making antivirals, molnupiravir and ritonavir, available to clinically extremely vulnerable NHS patients following exposure to covid-19.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 November 2021
Written question
To ask the Secretary of State for Health and Social Care, if he will set out his timeframe for making antivirals, molnupiravir and ritonavir, available to clinically extremely vulnerable NHS patients following exposure to covid-19.
Source: Commons
15 November 2021
Answer
On 20 October 2021 we announced that the Government had secured two COVID-19 oral antiviral treatments for United Kingdom patients. Molnupiravir (Lagevrio), one of the antivirals procured, received the Medicines and Healthcare products Regulatory Agency (...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-11-05/70315
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1366400
- uk · wq-1366400 · source updated 15 November 2021